223 related articles for article (PubMed ID: 18701049)
21. [Expression of p38MAPK in the hippocampal CA1 region of rats with Abeta25-35-induced Alzheimer disease].
Zhang GL; Yao L; DU Y; Zhang R; Bu N; Liu JJ; Yuan HF; Wu HQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1176-9. PubMed ID: 18676256
[TBL] [Abstract][Full Text] [Related]
22. Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid beta-infused rat by repressing amyloid beta accumulation.
Lee CL; Kuo TF; Wang JJ; Pan TM
J Neurosci Res; 2007 Nov; 85(14):3171-82. PubMed ID: 17663476
[TBL] [Abstract][Full Text] [Related]
23. Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels.
Christensen R; Marcussen AB; Wörtwein G; Knudsen GM; Aznar S
Exp Neurol; 2008 Mar; 210(1):164-71. PubMed ID: 18053988
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM
Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359
[TBL] [Abstract][Full Text] [Related]
25. Suppressive effects of melatonin on amyloid-beta-induced glial activation in rat hippocampus.
Shen Y; Zhang G; Liu L; Xu S
Arch Med Res; 2007 Apr; 38(3):284-90. PubMed ID: 17350477
[TBL] [Abstract][Full Text] [Related]
26. Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease.
Takeda S; Sato N; Niisato K; Takeuchi D; Kurinami H; Shinohara M; Rakugi H; Kano M; Morishita R
Brain Res; 2009 Jul; 1280():137-47. PubMed ID: 19464276
[TBL] [Abstract][Full Text] [Related]
27. Effects of memantine and donepezil on amyloid beta-induced memory impairment in a delayed-matching to position task in rats.
Yamada K; Takayanagi M; Kamei H; Nagai T; Dohniwa M; Kobayashi K; Yoshida S; Ohhara T; Takuma K; Nabeshima T
Behav Brain Res; 2005 Jul; 162(2):191-9. PubMed ID: 15904984
[TBL] [Abstract][Full Text] [Related]
28. Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning.
Holscher C; Gengler S; Gault VA; Harriott P; Mallot HA
Eur J Pharmacol; 2007 Apr; 561(1-3):85-90. PubMed ID: 17320856
[TBL] [Abstract][Full Text] [Related]
29. Study of the effect of inhibiting galanin in Alzheimer's disease induced in rats.
Baraka A; ElGhotny S
Eur J Pharmacol; 2010 Sep; 641(2-3):123-7. PubMed ID: 20639139
[TBL] [Abstract][Full Text] [Related]
30. Cerebral ischemia combined with beta-amyloid impairs spatial memory in the eight-arm radial maze task in rats.
Iwasaki K; Egashira N; Hatip-Al-Khatib I; Akiyoshi Y; Arai T; Takagaki Y; Watanabe T; Mishima K; Fujiwara M
Brain Res; 2006 Jun; 1097(1):216-23. PubMed ID: 16729978
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation.
Bisel BE; Henkins KM; Parfitt KD
Ann N Y Acad Sci; 2007 Feb; 1097():58-63. PubMed ID: 17413011
[TBL] [Abstract][Full Text] [Related]
32. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T
J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004
[TBL] [Abstract][Full Text] [Related]
33. Nicotine exacerbates tau phosphorylation and cognitive impairment induced by amyloid-beta 25-35 in rats.
Deng J; Shen C; Wang YJ; Zhang M; Li J; Xu ZQ; Gao CY; Fang CQ; Zhou HD
Eur J Pharmacol; 2010 Jul; 637(1-3):83-8. PubMed ID: 20363218
[TBL] [Abstract][Full Text] [Related]
34. Danggui-Shaoyao-San and its active fraction JD-30 improve Abeta-induced spatial recognition deficits in mice.
Hu ZY; Liu G; Yuan H; Yang S; Zhou WX; Zhang YX; Qiao SY
J Ethnopharmacol; 2010 Mar; 128(2):365-72. PubMed ID: 20117199
[TBL] [Abstract][Full Text] [Related]
35. Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice.
Lu P; Mamiya T; Lu LL; Mouri A; Niwa M; Hiramatsu M; Zou LB; Nagai T; Ikejima T; Nabeshima T
J Pharmacol Exp Ther; 2009 Oct; 331(1):319-26. PubMed ID: 19638571
[TBL] [Abstract][Full Text] [Related]
36. Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus.
Carrillo-Mora P; Méndez-Cuesta LA; Pérez-De La Cruz V; Fortoul-van Der Goes TI; Santamaría A
Behav Brain Res; 2010 Jul; 210(2):240-50. PubMed ID: 20219555
[TBL] [Abstract][Full Text] [Related]
37. Alteration of the sialylation pattern and memory deficits by injection of Aβ(25-35) into the hippocampus of rats.
Limón ID; Ramírez E; Díaz A; Mendieta L; Mayoral MÁ; Espinosa B; Guevara J; Zenteno E
Neurosci Lett; 2011 May; 495(1):11-6. PubMed ID: 21419829
[TBL] [Abstract][Full Text] [Related]
38. The effects of chronic estradiol treatment on working memory deficits induced by combined infusion of beta-amyloid (1-42) and ibotenic acid.
Hruska Z; Dohanich GP
Horm Behav; 2007 Sep; 52(3):297-306. PubMed ID: 17583706
[TBL] [Abstract][Full Text] [Related]
39. Amyloid-beta injection in rat amygdala alters tau protein but not mRNA expression.
Chambers CB; Sigurdsson EM; Hejna MJ; Lorens SA; Lee JM; Muma NA
Exp Neurol; 2000 Mar; 162(1):158-70. PubMed ID: 10716896
[TBL] [Abstract][Full Text] [Related]
40. [Effects of central administration of beta-amyloid peptide (25-35): pathomorphological changes in the hippocampus and impairments of spatial memory].
Stepanichev MIu; Zdobnova IM; Zarubenko II; Lazareva NA; Guliaeva NV
Zh Vyssh Nerv Deiat Im I P Pavlova; 2004; 54(5):705-11. PubMed ID: 15573708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
